Orforglipron oral GLP-1 Orforglipron oral GLP-1 may offer a convenience advantage because it is taken by mouth daily, and it does not require injections
Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets
Bottom line GERD and hiatus hernia are not contraindications to GLP-1RAs or tirzepatide
Research does show GHK-Cu: Stimulates collagen and glycosaminoglycan production Improves wound healing in laboratory and clinical settings Reduces inflammation and oxidative stress Supports healthier skin structure over time These effects are well documented in scientific literature, especially in wound care and tissue repair contexts
Always check your Mounjaro pen or vial to ensure it has not been exposed to freezing temperatures prior to use
10.3390/molecules23092334 225 WardP